EMIS Group plc reported FY21 results ahead of Edison Group's recently raised forecasts, with revenue up 6% y-o-y, adjusted operating profit up 11% and adjusted EPS up 10%. EMIS-X analytics is being adopted by both EMIS Health and EMIS Enterprise customers, supporting a more proactive approach to healthcare, and enhancements to the platform underpin the company’s integrated care systems strategy. Reflecting FY21 performance and recent bolt-on acquisitions, Edison upgrades its adjusted EPS forecasts by c 3% in FY22 and FY23. Compared to a global group of healthcare software peers, EMIS trades at a discount on all profitability valuation metrics. EMIS is a software supplier to the UK healthcare market, with two divisions: EMIS Health and EMIS Enterprise.
Download PDF • 601KB